Peter E. Barker

National Institute of Standards and Technology

Papers

Total Citations

H-Index

About

Peter E. Barker is a leading figure in the development of standardized assays for cancer early detection, with a particular focus on telomerase activity as a noninvasive biomarker. His foundational work includes the analytical validation of telomerase activity for cancer screening, a 2004 study that has garnered 30 citations and established critical benchmarks for clinical reliability. Barker further advanced the field by spearheading the preparation and characterization of candidate reference materials for telomerase assays, a 2005 contribution cited 18 times that addressed the pressing need for reproducibility in measuring telomerase in body fluids. By tackling the technical challenges of the telomerase repeat amplification protocol (TRAP), he helped pave the way for cost-effective, noninvasive cancer diagnostics. His efforts in creating standardized materials and validation frameworks have been instrumental in moving telomerase-based tests from research labs toward clinical utility, making him a key contributor to the infrastructure of cancer biomarker development.